PROVIDER PROFILE · NPI 1649249699
Saju EapenMD
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,025
Unique beneficiaries
—
Total services
11,603
Distinct HCPCS
16
Medicare payment
$111K
Peer benchmark
Total Medicare services vs. 108 Allergy/ Immunology providers in VA — top quintile (cohort median 3,446).
PRESCRIBING · PART D · 2024
Total Rx claims
919
Beneficiaries
—
Total drug cost
$114K
Distinct drugs
17
Brand share
21.7%
Top prescribed drugs
Azelastine Hcl252 claims
Fluticasone Propionate110 claims
Montelukast Sodium103 claims
Ipratropium Bromide84 claims
Fluticasone Furoate54 claims
QUALITY · MIPS · 2024
Final MIPS score
75.0
Quality
0.0
Cost
0.0
Improvement activities
0.0
Promoting interop.
0.0
Payment adjustment
0.00%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$2K
Payment records
67
By payment type
Food and Beverage$1K
Education$95
Top paying entities
Food and Beverage$1K
Education$95
REFERRAL NETWORK
Where Saju Eapen's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 3 inbound referrers · 0 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| SOLSTAS LAB PARTNERS GROUP LLC | 79 | 377 |
| CARILION MEDICAL CENTER | 49 | 174 |
| Thomas Fame Allergy/ Immunology · Salem, VA | 25 | 171 |
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE